It is a pharma private limited company based in Bengaluru, Karnataka, India, established in 2011.
2011 | Bengaluru, Karnataka, India | ActiveCortex Medipharma Private Limited, a active private limited company, was established on 03 March 2011 in Bengaluru, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74990KA2011PTC057346. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Nagaraj Dharanendra Vardhaman (Director), Manjula Nagaraj Vardhaman (Director). Past directors included Kashinath Guranna Marnoor, Bheemashankar Bhooprao Sadalapur, Santosh Chinchure. Its latest AGM occurred on 03 January 2022, with the balance sheet filed on 31 March 2021. It is based at Shop No 2 No 314 6Th Cross 40 Feet Main Road Pramod Layout Pantarpalya Rajarajeshwar, I Nagar, Bengaluru, Karnataka, 560039.
U74990KA2011PTC057346
057346
03 March 2011
₹0.20 M
₹0.20 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Cortex Medipharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagaraj Dharanendra Vardhaman | Director | 03 Mar 2011 | Current |
| Manjula Nagaraj Vardhaman | Director | 22 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Dec 2016 | Past |
| Pramod Abcsdd | Director | 26 Feb 2015 | Past |
| Pramod Abcsdd | Director | 22 Mar 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cortex Medipharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 17.66% decrease. The company also saw a substantial improvement in profitability, with a 86.14% increase in profit. The company's net worth Soared by an impressive increase of 14.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Cortex Medipharma had a promoter holding of 96.00% and a public holding of 4.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cortex Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cortex Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cortex Medipharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cortex Medipharma Private Limited last Annual general meeting of members was held on 03 Jan 2022 as per latest MCA records. was recorded as a recent event.
Progress on Cortex Medipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Bangalore. was documented.
Progress on Manjula Nagaraj Vardhaman was appointed as a Director was appointed as a Director on 22 Mar 2017 & has been associated with this company since 8 years 8 months . was documented.
Progress on Nagaraj Dharanendra Vardhaman was appointed as a Director was appointed as a Director on 03 Mar 2011 & has been associated with this company since 14 years 9 months . was documented.
Progress on Cortex Medipharma Private Limited was registered on 03 Mar 2011 with Roc Bangalore & aged 14 years 9 months as per MCA records. was documented.
The CIN of Cortex Medipharma Private Limited is U74990KA2011PTC057346.
Cortex Medipharma Private Limited is headquartered at Shop No 2 No 314 6Th Cross 40 Feet Main Road Pramod Layout Pantarpalya Rajarajeshwar, I Nagar, Bengaluru, Karnataka, 560039.
Cortex Medipharma Private Limited was incorporated on 03 March 2011.
The current directors of Cortex Medipharma Private Limited are
The primary industry of Cortex Medipharma Private Limited is Trade.
Cortex Medipharma Private Limited is unlisted.
The authorized capital of Cortex Medipharma Private Limited is ₹0.20 M, and the paid-up capital is ₹0.20 M.
The compliance status of Cortex Medipharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX